Towards optimization of cardiovascular stability in neonates with hypertrophic cardiomyopathy: uniqueness of the neonatal cardiovascular system
- PMID: 33510414
- DOI: 10.1038/s41372-021-00926-w
Towards optimization of cardiovascular stability in neonates with hypertrophic cardiomyopathy: uniqueness of the neonatal cardiovascular system
Comment on
-
Use of vasopressin in neonatal hypertrophic obstructive cardiomyopathy: case series.J Perinatol. 2021 Jan;41(1):126-133. doi: 10.1038/s41372-020-00824-7. Epub 2020 Sep 19. J Perinatol. 2021. PMID: 32951013
-
Vasopressin in neonatal hypertrophic cardiomyopathy: do perceived benefits translate to clinical outcome?J Perinatol. 2021 Apr;41(4):905-906. doi: 10.1038/s41372-021-00937-7. Epub 2021 Feb 18. J Perinatol. 2021. PMID: 33603108 No abstract available.
References
-
- Loomba R, Flores S, Bronicki RA. Vasopressin in neonatal hypertrophic cardiomyopathy: cosmetic or helpful? J Perinatol. 2020.
-
- Deorari AK, Saxena A, Singh M, Shrivastava S. Echocardiographic assessment of infants born to diabetic mothers. Arch Dis Child. 1989;64:721–4. - DOI
-
- Barbara DW, Hyder JA, Behrend TL, Abel MD, Schaff HV, Mauermann WJ. Safety of noncardiac surgery in patients with hypertrophic obstructive cardiomyopathy at a tertiary care center. J Cardiothorac Vasc Anesth. 2016;30:659–64. - DOI
-
- Way GL, Wolfe RR, Eshaghpour E, Bender RL, Jaffe RB, Ruttenberg HD. The natural history of hypertrophic cardiomyopathy in infants of diabetic mothers. J Pediatr. 1979;95:1020–5. - DOI
-
- Gobel FL, Norstrom LA, Nelson RR, Jorgensen CR, Wang Y. The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation. 1978;57:549–56. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
